Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus


  1. 2008
  2. Published

    Fatal neurogenic pulmonary edema in a patient with progressive multiple sclerosis.

    Bramow, S., Faber-Rod, J. C., Jacobsen, Christina, Kutzelnigg, A., Patrikios, P., Sørensen, Per Soelberg, Lassmann, H. & Laursen, H., 2008, In: Multiple Sclerosis. 14, 5, p. 711-715 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial

    Fazekas, F., Lublin, F. D., Li, D., Freedman, M. S., Hartung, H. P., Rieckmann, P., Sorensen, P. S., Sommerauer, B., Hanna, K. & Sørensen, Per Soelberg, 2008, In: Neurology. 71, 4, p. 265-271 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Intravenous polyclonal human immunoglobulins in multiple sclerosis

    Sørensen, Per Soelberg, 2008, In: Neurodegenerative Diseases. 5, 1, p. 8-15 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    REGARD: what can we learn from randomised, open-label, head-to-head studies?1

    Sørensen, Per Soelberg, 2008, In: Lancet Neurology. 7, 10, p. 864-866 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    The SH2D2A gene and susceptibility to multiple sclerosis

    Lorentzen, A. R., Smestad, C., Lie, B. A., Oturai, A. B., Akesson, E., Saarela, J., Myhr, K. M., Vartdal, F., Celius, E. G., Sørensen, Per Soelberg, Hillert, J., Spurkland, A. & Harbo, H. F., 2008, In: Journal of Neuroimmunology. 197, 2, p. 152-158 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis

    Hedegaard, C. J., Krakauer, M., Bendtzen, K., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Nielsen, Claus Henrik, 1 Oct 2008, In: Clinical Immunology. 129, 1, p. 80-9 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 2009
  9. Published

    How effective is natalizumab as second-line treatment for multiple sclerosis in daily clinical praxis?

    Sørensen, Per Soelberg, 2009, In: European Journal of Neurology. 16, 3, p. 287-288 1 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation

    Sellebjerg, Finn Thorup, Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E., Koch-Henriksen, N., Svejgaard, A., Sorensen, P. S., Sellebjerg, Finn Thorup, Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch-Henriksen, N., Svejgaard, A. & Sørensen, Per Soelberg, 2009, In: European Journal of Neurology. 16, 12, p. 1291-8 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

    Sellebjerg, Finn Thorup, Börnsen, L., Khademi, M., Krakauer, M., Olsson, T., Frederiksen, J. L., Sørensen, P. S., Sellebjerg, Finn Thorup, Börnsen, L., Khademi, M., Krakauer, M., Olsson, T., Battistini, J. L. & Sørensen, Per Soelberg, 2009, In: Neurology. 73, 23, p. 2003-10 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Management of patients with neutralizing antibodies against interferon-beta: stop IFN-beta therapy or wait for the antibodies to go away?

    Sørensen, Per Soelberg, 2009, In: European Journal of Neurology. 16, 1, p. 1-2 1 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...26 Next

ID: 11025